Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography

Figure 1

Thrombelastography measures between subjects with diabetes mellitus and without diabetes mellitus in platelet-poor plasma. (a) TEG-R: time to fibrin formation. (b) TEG-K: clot formation time. (c) TEG-MA: maximal fibrin clot strength. Mean ± 95% confidence interval.

(a)

(b)

(c)